These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 2290219)
21. [Methods for increasing the efficiency of aerosol inhalators]. Liutov GP Med Tekh; 2006; (1):3-5. PubMed ID: 16610276 [TBL] [Abstract][Full Text] [Related]
22. Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol. Raleigh SM; Verschoyle RD; Bowskill C; Pastorino U; Staniforth JN; Steele F; Dinsdale D; Carthew P; Lim CK; Silvester J; Gescher A Br J Cancer; 2000 Oct; 83(7):935-40. PubMed ID: 10970697 [TBL] [Abstract][Full Text] [Related]
23. The effect of Taleum (sodium cromoglycate) 1-mg inhalation aerosol in children with allergic asthma. Nagy B Ther Hung; 1994; 42(1):41-4. PubMed ID: 7761963 [TBL] [Abstract][Full Text] [Related]
24. [Aerosol generation and delivery systems for pulmonary drug administration: theory and practice]. Newhouse MT Z Gesamte Inn Med; 1993 Aug; 48(8):363-8. PubMed ID: 8379217 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway. Bitonti AJ; Dumont JA Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1106-18. PubMed ID: 16997417 [TBL] [Abstract][Full Text] [Related]
26. Inhalation steroids, some aspects and ways in the management of asthma. Majumdar SP; Kumar TR J Indian Med Assoc; 1994 Jul; 92(7):233-4. PubMed ID: 7963605 [TBL] [Abstract][Full Text] [Related]
27. Quantification of particle deposition in asymmetrical tracheobronchial model geometry. Farkas A; Balásházy I Comput Biol Med; 2008 Apr; 38(4):508-18. PubMed ID: 18336809 [TBL] [Abstract][Full Text] [Related]
28. Application of supercritical fluid to preparation of powders of high-molecular weight drugs for inhalation. Okamoto H; Danjo K Adv Drug Deliv Rev; 2008 Feb; 60(3):433-46. PubMed ID: 17996326 [TBL] [Abstract][Full Text] [Related]
33. Administration of Micronized Therapeutic Agents by Inhalation or Topical Application. Taplin GV; Bryan FA Science; 1947 May; 105(2732):502-3. PubMed ID: 17796177 [No Abstract] [Full Text] [Related]
34. [Therapeutics without vascular intrusion by medicinal aerosols]. BRUERE P Bull Mens Soc Med Mil Fr; 1946 Apr; 40():75-80. PubMed ID: 20991692 [No Abstract] [Full Text] [Related]
35. [Use of inhalation of ultrasonic aerosols and galvanic current in the treatment of patients with pulmonary tuberculosis]. Kim ACh; Krasnova TK; Romanova VIa Ter Arkh; 1987; 59(11):96-8. PubMed ID: 3502038 [TBL] [Abstract][Full Text] [Related]
36. Routes for drug delivery. Inhalation exposure for small animals serial blood collection in mice. Lab Anim (NY); 2008 Jan; 37(1):7. PubMed ID: 18094686 [No Abstract] [Full Text] [Related]
37. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids. Hadinoto K; Phanapavudhikul P; Kewu Z; Tan RB Int J Pharm; 2007 Mar; 333(1-2):187-98. PubMed ID: 17084567 [TBL] [Abstract][Full Text] [Related]
38. In situ and in vivo methods for pulmonary delivery. Eljamal M; Nagarajan S; Patton JS Pharm Biotechnol; 1996; 8():361-74. PubMed ID: 8791819 [No Abstract] [Full Text] [Related]
39. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects. Rogueda PG; Traini D Expert Opin Drug Deliv; 2007 Nov; 4(6):595-606. PubMed ID: 17970663 [TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]